市場調查報告書
商品編碼
1000916

中國的牙科用替代骨移植片市場分析 - 新型冠狀病毒感染疾病 (COVID-19)的影響 (2021年∼2027年):MedSuite (含牙科用替代骨移植片,牙科用阻隔薄膜)

China Dental Bone Graft Substitutes Market Analysis - COVID19 - 2021-2027 - MedSuite - Includes: Dental Bone Graft Substitute & Dental Barrier Membranes

出版日期: | 出版商: iData Research Inc. | 英文 147 Pages | 商品交期: 最快1-2個工作天內

價格

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

  • 全貌
  • 簡介
  • 目錄
簡介

本報告提供中國的牙科用替代骨移植片的市場相關分析,近來的市場主要趨勢及其背景情況,整體市場規模趨勢預測,各市場區隔詳細趨勢,主要企業 (共18家公司)的市場規模、銷售量、平均銷售價格 (ASP)、市場佔有率,新型冠狀病毒感染疾病 (COVID-19) 感染擴大的影響等調查。

分析對象市場:

牙科用替代骨移植片市場 - MedCore

牙科用阻隔薄膜市場 - MedCore

中國的牙科骨移植片市場洞察:

中國的牙科用骨移植替代品的市場規模,2020年達到了6620萬美元。還有在預測期間內預計以28.8%的年複合成長率成長,2027年達到3億8950萬美元。

牙科用生物材料的市場上現在進行中的主要趨勢,是隨著異體移植片、異質骨移植的銷售量增加,促進牙科骨移植片替代品 (BDGS) 市場成長。這個2個市場區隔的市場規模,以超過其他小型的合成材料的速度成長。

目錄
Product Code: iDATA_CHDBGS21_MS

Throughout this medical market research, the publisher analyzed 18 dental bone graft substitutes companies in China and utilized their comprehensive methodology to understand the Market Sizes, Unit Sales, ASPs, Company Market Shares, and to create accurate forecasts.

While this MedSuite report contains all of the China Dental Bone Graft Substitutes Market analysis, each of the market segments is also available for purchase as a stand-alone report, MedCore.

Markets Covered:

Dental Bone Graft Substitutes Market - MedCore

Dental Barrier Membranes Market - MedCore

Chinese Dental Bone Graft Substitutes Market Insights

Overall, the China dental bone graft substitutes and other biomaterials market was valued at $66.2 million in 2020. This is expected to increase over the forecast period at a CAGR of 28.8% to reach $389.5 million in 2027.

An ongoing trend within the market for dental biomaterials is the growth within the DBGS market, driven by unit sales growth in the allograft and xenograft segments. Growth in both segments is set to outpace the growth rate seen in the minor synthetic materials segment.

Geistlich, a globally recognized leader in regenerative materials, dominated the growing xenograft market in China. Geistlich's success in the market has generated significant growth for xenograft materials, as the company is a globally recognized and trusted name. Through setting up an affiliate in China, the company has been able to combat local cultural barriers and build brand awareness in the market. The company is expected to maintain its share of the market, despite increasing competition from domestic companies.